LOOK AT THIS IF YOU'RE INTERESTED IN:
Learning about Sri Lanka’s experience transitioning from Gavi support.
HOW YOU CAN USE THIS MATERIAL:
As your country prepares to transition away from Gavi support, learn from Sri Lanka’s experiences, including successes and challenges, with securing domestic financing, strengthening local capacity, and introducing new vaccines.
Sri Lanka’s national immunization program is cited globally and regionally as a successful model. The Expanded Immunization Program (EPI) maintains high coverage (98-100%) of all vaccines it offers, and a low incidence of vaccine-preventable diseases covered by the program. Since 2016, the immunization program has also been self-funded. On November 19th, speakers reflected on Sri Lanka’s experience transitioning from Gavi support and share a current perspective on challenges related to sustainability and maintaining the gains made in disease control over the past 30 years.
The speakers presented on how Sri Lanka:
- Secured domestic financing, and what other countries can learn from this process
- Fostered local capacity and leadership even prior to Gavi support
- Managed the transition to post-Gavi procurement and potential challenges
- Makes decisions on new vaccine introduction
- Dr Nihal Abeysinghe, Deputy Director, Institute for Research and Development
- Dr Sudath Peiris, Technical Officer, World Health Organization
- Dr. Sudath Samaraweera, Chief Epidemiologist, Epidemiology Unit, Ministry of Health Sri Lanka
Session Slides: English